噬菌体疗法
抗生素
生物
抗生素治疗
抗生素耐药性
微生物学
细菌
抗药性
噬菌体
重症监护医学
医学
遗传学
大肠杆菌
基因
作者
Kaitlyn E. Kortright,Benjamin K. Chan,Jonathan L. Koff,Paul E. Turner
标识
DOI:10.1016/j.chom.2019.01.014
摘要
Phage therapy, long overshadowed by chemical antibiotics, is garnering renewed interest in Western medicine. This stems from the rise in frequency of multi-drug-resistant bacterial infections in humans. There also have been recent case reports of phage therapy demonstrating clinical utility in resolving these otherwise intractable infections. Nevertheless, bacteria can readily evolve phage resistance too, making it crucial for modern phage therapy to develop strategies to capitalize on this inevitability. Here, we review the history of phage therapy research. We compare and contrast phage therapy and chemical antibiotics, highlighting their potential synergies when used in combination. We also examine the use of animal models, case studies, and results from clinical trials. Throughout, we explore how the modern scientific community works to improve the reliability and success of phage therapy in the clinic and discuss how to properly evaluate the potential for phage therapy to combat antibiotic-resistant bacteria.
科研通智能强力驱动
Strongly Powered by AbleSci AI